HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT

Francesca Bruzzese, Alessandra Leone, Monia Rocco, Carmine Carbone, Geny Piro, Michele Caraglia, Elena Di Gennaro, Alfredo Budillon

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT'. Together they form a unique fingerprint.

Medicine & Life Sciences

Mathematics

Engineering & Materials Science

Chemical Compounds

Earth & Environmental Sciences